Two cases of MT-ND5 -related mitochondrial disorder misdiagnosed as seronegative neuromyelitis optica spectrum disorder

Abstract

Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune disease primarily affecting the optic nerves and spinal cord, which is usually associated with anti-aquaporin-4 antibodies. Here, we present two individuals who were negative for anti-aquaporin-4 antibodies and were initially diagnosed with seronegative NMOSD. Each patient’s clinical course and radiographic features raised suspicion for an alternative disease process. Both individuals were found to have pathogenic variants of MT-ND5, encoding subunit 5 of mitochondrial complex I, ultimately leading to a revised diagnosis of a primary mitochondrial disorder. These cases illustrate the importance of biochemical and genetic testing in atypical cases of NMOSD.

Keywords

Neuromyelitis optica relapsing/remitting mitochondrial disease genetics

Get full access to this article

View all access options for this article.

References

Santoro

Paulsen

. Biotinidase deficiency as a mimic of neuromyelitis optica spectrum disorder in childhood. JAMA Neurol 2021; 78(1): 118–120.

Lax

Maddison

, et al. MT-ND5 mutation exhibits highly variable neurological manifestations at low mutant load. EBioMedicine 2018; 30: 86–93.

Naini

Kaufmann

, et al. Novel mitochondrial DNA ND5 mutation in a patient with clinical features of MELAS and MERRF. Arch Neurol 2005; 62(3): 473–476.

Valentino

Barboni

Rengo

, et al. The 13042G –> A/ND5 mutation in mtDNA is pathogenic and can be associated also with a prevalent ocular phenotype. J Med Genet 2006; 43(7): e38.

Baertling

Rodenburg

Schaper

, et al. A guide to diagnosis and treatment of Leigh syndrome. J Neurol Neurosurg Psychiatry 2014; 85(3): 257–265.

Yatsuga

Povalko

Nishioka

, et al. MELAS: A nationwide prospective cohort study of 96 patients in Japan. Biochim Biophys Acta 2012; 1820(5): 619–624.

Gorman

Chinnery

DiMauro

, et al. Mitochondrial diseases. Nat Rev Dis Primers 2016; 2(1): 16080.

Pyle

Taylor

Durham

, et al. Depletion of mitochondrial DNA in leucocytes harbouring the 3243A->G mtDNA mutation. J Med Genet 2007; 44(1): 69–74.

Campbell

Krishnan

Deschauer

, et al. Dissecting the mechanisms underlying the accumulation of mitochondrial DNA deletions in human skeletal muscle. Hum Mol Genet 2014; 23(17): 4612–4620.

10.

Zhao

Zhang

Wang

. Magnetic resonance imaging findings in the pregeniculate visual pathway in Leber hereditary optic neuropathy. J Neuroophthalmol 2022; 42(1): e153–e158.

11.

Moon

Kim

Han

, et al. Clinical and optic disc characteristics of patients showing visual recovery in Leber hereditary optic neuropathy. J Neuroophthalmol 2020; 40(1): 15–21.

12.

Bindu

Sonam

Chiplunkar

, et al. Mitochondrial leukoencephalopathies: A border zone between acquired and inherited white matter disorders in children? Mult Scler Relat Disord 2018; 20: 84–92.

13.

Harding

Sweeney

Miller

, et al. Occurrence of a multiple sclerosis-like illness in women who have a Leber’s hereditary optic neuropathy mitochondrial DNA mutation. Brain 1992; 115(pt 4): 979–989.

14.

Yu-Wai-Man

Spyropoulos

Duncan

, et al. A multiple sclerosis-like disorder in patients with OPA1 mutations. Ann Clin Transl Neurol 2016; 3(9): 723–729.

15.

Bargiela

Chinnery

. Mitochondria in neuroinflammation—Multiple sclerosis (MS), Leber hereditary optic neuropathy (LHON) and LHON-MS. Neurosci Lett 2019; 710: 132932.

16.

Wingerchuk

Banwell

Bennett

, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 2015; 85(2): 177–189.